Catalyst
Analysts have issued two recent Buy or Strong Buy ratings for BLDR, indicating strong institutional optimism about the stock.
Risk
Fund flow data indicates an overall negative trend in fund inflow, suggesting that institutional investors may be reducing exposure to BLDR.
Generated at20:5901/20/2026by
Aime